Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man-Tzu Wang

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancers|June 28, 2023
Regulations of Tumor Microenvironment by ProstaglandinsJeffrey Z Nie, Man-Tzu Wang, Daotai Nie
Cancer Metastasis Reviews|September 4, 2007
Cyclooxygenases, prostanoids, and tumor progressionMan-Tzu Wang, Kenneth V Honn, Daotai Nie
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Role of Rho GTPases in breast cancerYong Tang, Lola Olufemi, Man-Tzu Wang, et al.
Cancer Research|November 3, 2007
Human pregnane X receptor and resistance to chemotherapy in prostate cancerYakun Chen, Yong Tang, Man-Tzu Wang, et al.
Cell|November 23, 2015
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt SignalingMan-Tzu Wang, Matthew Holderfield, Jacqueline Galeas, et al.
Nature Communications|July 13, 2019
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancerMan-Tzu Wang, Nicole Fer, Jacqueline Galeas, et al.
International Journal of Cancer|December 18, 2008
Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancerYong Tang, Man-Tzu Wang, Yakun Chen, et al.
Cancer Research|January 4, 2008
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase RhoDaotai Nie, Yande Guo, Dianer Yang, et al.
Developmental Cell|January 11, 2022
Sensing plasma membrane pore formation induces chemokine production in survivors of regulated necrosisWeihong Wang, Joshua S Prokopec, Yixin Zhang, et al.
Biorxiv : the Preprint Server for Biology|May 2, 2025
<i>CASTOR1</i> : A Novel Tumor Suppressor Linking mTORC1 and KRAS Pathways in Tumorigenesis and Resistance to KRAS-Targeted Therapies in Non-Small Cell Lung CancerXian Wang, Ling Ding, Shenyu Sun, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|June 28, 2023
Regulations of Tumor Microenvironment by ProstaglandinsJeffrey Z Nie, Man-Tzu Wang, Daotai Nie
Cancer Metastasis Reviews|September 4, 2007
Cyclooxygenases, prostanoids, and tumor progressionMan-Tzu Wang, Kenneth V Honn, Daotai Nie
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Role of Rho GTPases in breast cancerYong Tang, Lola Olufemi, Man-Tzu Wang, et al.
Cancer Research|November 3, 2007
Human pregnane X receptor and resistance to chemotherapy in prostate cancerYakun Chen, Yong Tang, Man-Tzu Wang, et al.
Cell|November 23, 2015
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt SignalingMan-Tzu Wang, Matthew Holderfield, Jacqueline Galeas, et al.
Nature Communications|July 13, 2019
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancerMan-Tzu Wang, Nicole Fer, Jacqueline Galeas, et al.
International Journal of Cancer|December 18, 2008
Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancerYong Tang, Man-Tzu Wang, Yakun Chen, et al.
Cancer Research|January 4, 2008
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase RhoDaotai Nie, Yande Guo, Dianer Yang, et al.
Developmental Cell|January 11, 2022
Sensing plasma membrane pore formation induces chemokine production in survivors of regulated necrosisWeihong Wang, Joshua S Prokopec, Yixin Zhang, et al.
Biorxiv : the Preprint Server for Biology|May 2, 2025
<i>CASTOR1</i> : A Novel Tumor Suppressor Linking mTORC1 and KRAS Pathways in Tumorigenesis and Resistance to KRAS-Targeted Therapies in Non-Small Cell Lung CancerXian Wang, Ling Ding, Shenyu Sun, et al.
Pageof 2